{"id":3790,"count":5,"description":"Hypotyre\u00f3za \u2014 sn\u00ed\u017een\u00e1 funkce \u0161t\u00edtn\u00e9 \u017el\u00e1zy \u2014 postihuje p\u0159ibli\u017en\u011b 5 % dosp\u011bl\u00fdch celosv\u011btov\u011b<\/strong>, p\u0159i\u010dem\u017e \u017eeny jsou diagnostikov\u00e1ny p\u011btkr\u00e1t a\u017e desetkr\u00e1t \u010dast\u011bji ne\u017e mu\u017ei. \u0160t\u00edtn\u00e1 \u017el\u00e1za se nach\u00e1z\u00ed v p\u0159edn\u00ed \u010d\u00e1sti krku a produkuje dva hormony: tyroxin (T4)<\/strong> a trijodtyronin (T3)<\/strong>, kter\u00e9 spole\u010dn\u011b reguluj\u00ed metabolickou rychlost ka\u017ed\u00e9 bu\u0148ky v t\u011ble. Kdy\u017e \u017el\u00e1za sel\u017ee \u2013 nej\u010dast\u011bji v d\u016fsledku autoimunitn\u00edho po\u0161kozen\u00ed (Hashimotova tyreoiditida), chirurgick\u00e9ho z\u00e1kroku kv\u016fli uzl\u016fm nebo rakovin\u011b, radioj\u00f3dov\u00e9 ablace, vrozen\u00e9 absence nebo t\u011b\u017ek\u00e9ho nedostatku j\u00f3du \u2013 p\u0159\u00edznaky se objevuj\u00ed postupn\u011b: \u00fanava, p\u0159ib\u00fdv\u00e1n\u00ed na v\u00e1ze, nesn\u00e1\u0161enlivost chladu, z\u00e1cpa, such\u00e1 k\u016f\u017ee, vypad\u00e1v\u00e1n\u00ed vlas\u016f, deprese a zaml\u017een\u00e9 my\u0161len\u00ed. Nel\u00e9\u010den\u00e1 hypotyre\u00f3za v t\u011bhotenstv\u00ed zvy\u0161uje riziko potratu a naru\u0161uje neurov\u00fdvoj plodu. Diagn\u00f3za je biochemick\u00e1: zv\u00fd\u0161en\u00fd hormon stimuluj\u00edc\u00ed \u0161t\u00edtnou \u017el\u00e1zu (TSH)<\/strong> s n\u00edzkou nebo hrani\u010dn\u00ed hladinou voln\u00e9ho T4<\/strong>.\n\nTreatment is hormone replacement. The first-line drug is levothyroxin<\/strong> — synthetic T4 — taken once daily on an empty stomach. Levothyroxine has a long half-life (~7 days) which produces smooth blood levels with simple once-daily dosing. The body converts T4 to the more active T3 in peripheral tissues exactly as it does with the natural hormone, which is why most patients feel completely well on T4 alone. Dose is titrated against TSH every 6–8 weeks until the level sits in the target range (usually 0.5–2.5 mIU\/L), then monitored annually.\n\nLevothyroxine (T4) brands stocked at MedsBase\nAll four brands below contain the identical active ingredient — levothyroxin sodn\u00fd<\/strong>. Li\u0161\u00ed se v\u00fdrobcem, pomocn\u00fdmi l\u00e1tkami a cenou. Jakmile je va\u0161e TSH stabiln\u00ed na jedn\u00e9 zna\u010dce, setrv\u00e1n\u00ed u n\u00ed zabr\u00e1n\u00ed mal\u00fdm rozd\u00edl\u016fm v biologick\u00e9 dostupnosti, kter\u00e9 mohou posunout TSH mimo c\u00edlov\u00e9 rozmez\u00ed.\n\nEltroxin<\/strong><\/a> \u2014 GlaxoSmithKline (GSK), 100 mcg tableta. Celosv\u011btov\u011b uzn\u00e1van\u00e1 zna\u010dka pou\u017e\u00edvan\u00e1 od 60. let 20. stolet\u00ed; stejn\u00e1 molekula jako Synthroid a Levoxyl.\n0,5 mg, 1 mg, 2 mg<\/strong><\/a> \u2014 Abbott India, pln\u00e9 rozmez\u00ed titrace 25\/50\/100\/125\/150 mcg. Nej\u010dast\u011bji p\u0159edepisovan\u00fd levothyroxin v Indii.\nThyrox<\/strong><\/a> \u2014 Macleods Pharmaceuticals, 25\/100\/125\/200 mcg. Zahrnuje vy\u0161\u0161\u00ed s\u00edlu 200 mcg vhodnou pro potla\u010den\u00ed TSH po tyreoidektomii.\nL-Thyroid<\/strong><\/a> — budget option, full 25 to 150 mcg titration range.\n\n\nLiothyronine (T3) — second-line\nLiothyronin 25 mcg<\/strong><\/a> is synthetic T3 — about four times more potent than levothyroxine, with a much shorter half-life (~24 hours). Liothyronine bypasses the T4-to-T3 conversion step entirely. Its place in therapy is narrow:\n\nA mal\u00e1 p\u0159idan\u00e1 d\u00e1vka spolu s levothyroxinem<\/strong> in selected patients with persistent hypothyroid symptoms despite a normal TSH on T4 monotherapy — usually a specialist endocrinology decision after other causes are excluded.\nShort-term p\u0159\u00edpravek pro vy\u0161et\u0159en\u00ed \u0161t\u00edtn\u00e9 \u017el\u00e1zy p\u0159i podez\u0159en\u00ed na rakovinu<\/strong> (umo\u017e\u0148uje rychlej\u0161\u00ed vzestup TSH po vysazen\u00ed).\nMyxed\u00e9mov\u00e9 k\u00f3ma<\/strong> in hospital, given intravenously alongside T4.\nOff-label augmentation in deprese rezistentn\u00ed na l\u00e9\u010dbu<\/strong>.\n\nLiothyronine is ne<\/strong> a wholesale replacement for levothyroxine and is not a weight-loss drug — misuse in euthyroid people causes atrial fibrillation, bone loss and muscle wasting. The Cochrane systematic review found no consistent benefit of T4+T3 over T4 monotherapy for routine quality-of-life improvement.\n\nThyroid nutritional support — not a treatment substitute\nThyropace<\/strong><\/a> je dopln\u011bk stravy obsahuj\u00edc\u00ed L-tyrosin a j\u00f3d. Je za\u0159azen do t\u00e9to kategorie, proto\u017ee nutri\u010dn\u011b podporuje funkci \u0161t\u00edtn\u00e9 \u017el\u00e1zy, ale nejedn\u00e1 se o ne<\/strong> a substitute for levothyroxine in diagnosed hypothyroidism. Thyropace can be appropriate for confirmed mild iodine deficiency or as adjunct nutritional support during pregnancy. It should be avoided in autoimmune Hashimoto’s thyroiditis, Graves’ disease, and before radioiodine scanning — excess iodine flares autoimmunity and complicates radio-tracer imaging.\n\nCritical absorption rules for any T4 or T3 product\nLevothyroxine and liothyronine absorption are dramatically reduced by food, coffee, soy and several common medications. The rules below are essential, not optional:\n\nTake on an nala\u010dno<\/strong>, first thing in the morning, with plain water.\nWait 30\u201360 minut<\/strong> before any food, coffee or other tablet.\nSeparate from v\u00e1pn\u00edku, \u017eeleza, ho\u0159\u010d\u00edku, zinku, hlin\u00edku<\/strong> supplements \/ antacids by at least 4 hours.\nSeparate from inhibitory protonov\u00e9 pumpy<\/strong> (omeprazole, esomeprazole, pantoprazole) — gastric acid is needed for full absorption.\nSeparate from cholestyramin, sevelamer, orlistat<\/strong> nejm\u00e9n\u011b o 4 hodiny.\nT\u011bhotenstv\u00ed:<\/strong> pot\u0159eba levothyroxinu stoup\u00e1 o 25\u201350 % v polovin\u011b t\u011bhotenstv\u00ed \u2014 kontrolujte TSH ka\u017ed\u00e9 4 t\u00fddny v prvn\u00ed polovin\u011b t\u011bhotenstv\u00ed.\nStar\u0161\u00ed dosp\u011bl\u00ed \/ kardiaci:<\/strong> start low (25–50 mcg) and titrate slowly to avoid triggering ischaemia or atrial fibrillation.\n\n\nEvery product in this category is dispatched from a v\u00fdrobce certifikovan\u00e9ho WHO-GMP<\/strong>, generick\u00fd l\u00e9k schv\u00e1len\u00fd FDA, kde je to mo\u017en\u00e9, s diskr\u00e9tn\u00edm balen\u00edm a celosv\u011btovou dopravou. Ka\u017ed\u00e1 str\u00e1nka produktu obsahuje tabulku titrace TSH, \u00fapln\u00fd seznam interakc\u00ed l\u00e9k\u016f, profil vedlej\u0161\u00edch \u00fa\u010dink\u016f p\u0159i p\u0159ed\u00e1vkov\u00e1n\u00ed vs. nedostate\u010dn\u00e9 l\u00e9\u010db\u011b a panel ru\u010dn\u011b vybran\u00fdch alternativn\u00edch p\u0159\u00edpravk\u016f.","link":"https:\/\/medsbase.com\/cs\/underactive-thyroid-treatment\/","name":"L\u00e9\u010dba hypoaktivn\u00ed \u0161t\u00edtn\u00e9 \u017el\u00e1zy","slug":"underactive-thyroid-treatment","taxonomy":"product_cat","parent":3223,"meta":[],"menu_order":0,"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product_cat\/3790","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product_cat"}],"about":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/taxonomies\/product_cat"}],"up":[{"embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product_cat\/3223"}],"wp:post_type":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product?product_cat=3790"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}